Thirty-two patients with chronic cardiac failure underwent 24-hour ambulatory
electrocardiographic monitoring on 2 separate occasions: 20 patients before and during …

The effects of Captopril and placebo were compared in 18 patients with chronic heart failure
and angina pectoris with use of a double-blind crossover trial design. Symptoms were …

BACKGROUND Treatment with angiotensin converting enzyme inhibitors has been shown
to be beneficial in patients with heart failure and myocardial infarction. Experimental studies …

The effects of captopril (CPT), an oral angiotensin-converting enzyme (ACE) inhibitor, on
systemic renal and coronary hemodynamics were studied in 22 patients with severe …

The acute hemodynamic effects, long-term clinical efficacy, and safety of the oral
angiotensin-converting enzyme inhibitor, captopril, were assessed in a multicenter …

The hemodynamic and hormonal responses to acute and chronic captopril therapy and to its
temporary withdrawal were studied in seven patients with congestive heart failure. Maximal …

The coronary hemodynamic effects of vasodilator therapy with angiotensin-converting
enzyme inhibitors (captopril arid teprotide) were studied in 11 patients with ischemic heart …

SUMMARY Captopril (SQ 14,225), an oral angiotensin converting-enzyme inhibitor, was
administered to 11 patients with severe congestive heart failure (CHF). Peak effect was …

Results from a large multicenter study and from the published literature suggest that
captopril can improve survival in patients with advanced heart failure. The survival status of …

Although the short-term hemodynamic and clinical responses to angiotensin-converting
enzyme inhibition in patients with congestive heart failure (CHF) are well known, little …